ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
Alongside the portable oxygen concentrator, Dynarex has expanded its Resp-O₂ closed suction catheter range with new models developed specifically for infant and peadiatric patients.
imphoenix82
The acquisition of Advanced Medical Solutions will expand H.B. Fuller’s capabilities across tissue bonding adhesives, tapes and dressings and formulated biosurgicals.
imphoenix82
Haier Biomedical launched the HAB80-60KA / HAB80-60KB automated ultra-low temperature sample storage system at the Europe Biobank Week 2026, while at Interphex Week Tokyo 2026, the company unveiled the DWL368BPST ultra-low temperature freezer designed for laboratories with limited space.
imphoenix82
Under amended Drug Rules, manufacturers of vaccines, antimicrobials, narcotic and psychotropic drugs, and anti-cancer medicines will be required to print or affix a Bar Code or Quick Response (QR) Code on the packaging label.
imphoenix82
As part of the Jan Vishwas reforms, five provisions of the Clinical Establishments Act, 2010 were rationalised. Read on to know the changes…
imphoenix82
The US Food and Drug Administration (FDA) has approved Pfizer’s IBRANCE (palbociclib) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy as a maintenance treatment for adults with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-positive (HER2+) locally advanced or metastatic breast cancer following induction treatment. IBRANCE is an oral inhibitor of […]
imphoenix82
WHO is encouraging all countries to begin newborn screening with priority conditions and gradually expand as healthcare capacity grows.
imphoenix82
The regulator said it had received reports that ART media and related products were being supplied to unregistered facilities, thereby posing risk to patient health and welfare.
imphoenix82
The move follows a public notice issued on February 11, 2026, seeking feedback on the existing exemption list covering 354 medical devices
imphoenix82
The approval of Satri-cel in China marks the first time a CAR-T therapy for a solid tumour has successfully reached the market, offering new hope to patients with advanced gastric cancer.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
